| 摘要 |
The present invention is related to the pharmaceutical industry in general, and to the industry for manufacturing pharmaceutical products intended to prevent diabetic patients from cardiovascular risks. The advantages of the present composition compared to further drugs are that it reduces collateral effects caused by drugs for controlling both pathologies; it reduces cardiovascular risks, as well as side effects caused by the formula components; it achieves other synergystics effects by combining an antidiabetic agent along with a dyslipidaemic agent. The inventive composition consists in the combination of (i) a hypoglycemic agent, (ii) a hypolipemiant agent and (iii) a vitamin. ?? ?? ?? ??.
|
